(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine
- CAS
- 1807642-41-6
- Formula
- C16H14FN3O2S
- MW
- 331.4 g/mol
VQ-034678
Impurity reference standards
Vonoprazan impurities & reference standards
Characterised Vonoprazan impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
60reference materials
1nitrosamine impurities
COAHPLC · NMR · MS on request
Parent API: Vonoprazan
881681-00-1 · C17H16FN3O2S
(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanol
- CAS
- 2169271-28-5
- Formula
- C16H13FN2O3S
- MW
- 332.4 g/mol
VQ-024025
1-((5-Chloropyridin-3-yl)sulfonyl)-5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde
- CAS
- 2514742-82-4
- Formula
- C16H10ClFN2O3S
- MW
- 364.8 g/mol
VQ-045026
1-(1-((1,6-Dihydropyridin-3-yl)sulfonyl)-5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 2416241-95-5
- Formula
- C17H18FN3O2S
- MW
- 347.4 g/mol
VQ-028748
1-(5-(2-Fluorophenyl)-1-((1,4,5,6-tetrahydropyridin-3-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 2416241-97-7
- Formula
- C17H20FN3O2S
- MW
- 349.4 g/mol
VQ-028736
1-(5-(2-Fluorophenyl)-1-(pyridin-2-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 928615-46-7
- Formula
- C17H16FN3O2S
- MW
- 345.4 g/mol
VQ-044438
1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanimine
- CAS
- 2127152-98-9
- Formula
- C17H14FN3O2S
- MW
- 343.4 g/mol
VQ-034685
1-(5-(2-Fluorophenyl)-1-(pyridin-4-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 2771609-43-7
- Formula
- C17H16FN3O2S
- MW
- 345.4 g/mol
VQ-034680
1-(5-(2-Fluorophenyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine
- CAS
- 3058423-29-0
- Formula
- C23H21F2N3
- MW
- 377.4 g/mol
VQ-044445
1-(5-(2-Fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 1610043-62-3
- Formula
- C12H13FN2
- MW
- 204.24 g/mol
VQ-028732
1-(5-(2,6-Difluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 928325-41-1
- Formula
- C17H15F2N3O2S
- MW
- 363.4 g/mol
VQ-028745
1-(5-(3-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 881733-45-5
- Formula
- C17H16FN3O2S
- MW
- 345.4 g/mol
VQ-035267
1-(5-(4-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
- CAS
- 881733-36-4
- Formula
- C17H16FN3O2S
- MW
- 345.4 g/mol
VQ-028741
2-Chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
- CAS
- 1240948-72-4
- Formula
- C11H6ClFN2
- MW
- 220.63 g/mol
VQ-034677
2-Chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carboxaldehyde
- CAS
- 2169267-53-0
- Formula
- C11H7ClFNO
- MW
- 223.63 g/mol
VQ-028747
5-((2-(2-Fluorophenyl)-4-((methylamino)methyl)-1H-pyrrol-1-yl)sulfonyl)-1,2,3,4-tetrahydropyridin-2-ol
- CAS
- 2416241-96-6
- Formula
- C17H20FN3O3S
- MW
- 365.4 g/mol
VQ-028737
5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile
- CAS
- 1807642-39-2
- Formula
- C16H10FN3O2S
- MW
- 327.3 g/mol
VQ-028740
5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxylic Acid
- CAS
- 1883595-37-6
- Formula
- C16H11FN2O4S
- MW
- 346.3 g/mol
VQ-024026
5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic Acid
- CAS
- 1883595-38-7
- Formula
- C11H8FNO2
- MW
- 205.18 g/mol
VQ-028738
5-(2,4-Difluorophenyl)-1H-pyrrole-3-carbaldehyde
- CAS
- 2827733-29-7
- Formula
- C11H7F2NO
- MW
- 207.18 g/mol
VQ-045011
5-(2,6-Difluorophenyl)-1H-pyrrole-3-carbaldehyde
- CAS
- 928324-50-9
- Formula
- C11H7F2NO
- MW
- 207.18 g/mol
VQ-044479
5-Phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
- CAS
- 881676-90-0
- Formula
- C16H12N2O3S
- MW
- 312.3 g/mol
VQ-042939
Ethyl 2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carboxylate
- CAS
- 881674-01-7
- Formula
- C13H11ClFNO2
- MW
- 267.68 g/mol
VQ-034683
Ethyl 2-cyano-4-(2-fluorophenyl)-4- oxobutanoate
- CAS
- 881673-98-9
- Formula
- C13H12FNO3
- MW
- 249.24 g/mol
VQ-034682
Ethyl 5-(2-fluorophenyl)-1H-pyrrole-3-carboxylate
- CAS
- 881674-06-2
- Formula
- C13H12FNO2
- MW
- 233.24 g/mol
VQ-034681
N-((5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)-N-methylaspartic Acid
- CAS
- 2170020-79-6
- Formula
- C21H20FN3O6S
- MW
- 461.5 g/mol
VQ-028734
N-Methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine
- CAS
- 881732-90-7
- Formula
- C17H17N3O2S
- MW
- 327.4 g/mol
VQ-024027
Vonoprazan Impurity 283 (Intermediate Stage I)
- CAS
- 928324-73-6
- Formula
- C16H11FN2O3S
- MW
- 330.3 g/mol
In stock
FAQs — Vonoprazan impurities
Which Vonoprazan impurities do you supply?
We list 60 Vonoprazan-related reference materials, including process impurities, degradation products, nitrosamine impurities and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Vonoprazan impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Vonoprazan impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Vonoprazan impurity standards
We reply within one business day with price, pack options, lead time and documentation.